| RS1057519995 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian neoplasm, Li-Fraumeni syndrome |
| RS1057519996 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Ovarian neoplasm |
| RS1057519997 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome, Ovarian neoplasm |
| RS1057519998 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1057519999 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome |
| RS1057520000 |
TP53
|
Health Risk |
Pathogenic/Likely pathogenic |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1057520001 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Ovarian neoplasm |
| RS1057520002 |
TP53
|
Health Risk |
Pathogenic/Likely pathogenic |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1057520003 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1057520004 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1057520005 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Lip and oral cavity carcinoma |
| RS1057520006 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1057520007 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1057520008 |
TP53
|
Health Risk |
Pathogenic/Likely pathogenic |
Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome |
| RS1057520032 |
KIT
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, B Lymphoblastic Leukemia/Lymphoma with t(v |
| RS1057520039 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Melanoma |
| RS1057520041 |
STK11
|
Health Risk |
Likely pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS1057520042 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS1057520046 |
TUBB
|
Health Risk |
Likely pathogenic |
— |
| RS1057520049 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS1057520050 |
KANSL1
|
Health Risk |
Likely pathogenic |
— |
| RS1057520053 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1057520055 |
GRIN1
|
Health Risk |
Likely pathogenic |
— |
| RS1057520056 |
MED13L
|
Health Risk |
Likely pathogenic |
— |
| RS1057520058 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1057520063 |
GLI3
|
Health Risk |
Pathogenic/Likely pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS1057520064 |
HIKESHI
|
Health Risk |
Likely pathogenic |
— |
| RS1057520065 |
HNRNPU
|
Health Risk |
Pathogenic |
— |
| RS1057520070 |
CCM2
|
Health Risk |
Pathogenic |
— |
| RS1057520072 |
CREBBP
|
Health Risk |
Pathogenic |
— |
| RS1057520076 |
IFIH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Singleton-Merten syndrome 1, Aicardi-Goutieres syndrome 7 |
| RS1057520078 |
OCRL
|
Health Risk |
Pathogenic |
— |
| RS1057520080 |
ADGRV1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1057520081 |
TRIOBP
|
Health Risk |
Likely pathogenic |
— |
| RS1057520085 |
TMEM216
|
Health Risk |
Likely pathogenic |
Joubert syndrome 2, Joubert syndrome |
| RS1057520088 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1057520090 |
KAT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS1057520098 |
TCN2
|
Health Risk |
Pathogenic/Likely pathogenic |
Transcobalamin II deficiency, Transcobalamin II deficiency |
| RS1057520099 |
MT-TH
|
Health Risk |
Conflicting classifications of pathogenicity |
MELAS syndrome, MELAS syndrome |
| RS1057520100 |
DOCK7
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS1057520101 |
AIMP1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1057520104 |
ERCC4
|
Health Risk |
Likely pathogenic |
— |
| RS1057520107 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
MYH9-related disorder, MYH9-related disorder |
| RS1057520108 |
PGAP3
|
Health Risk |
Likely pathogenic |
— |
| RS1057520109 |
GCK
|
Health Risk |
Pathogenic |
Monogenic diabetes, Maturity-onset diabetes of the young |
| RS1057520110 |
ELANE
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1057520111 |
CHST3
|
Health Risk |
Likely pathogenic |
— |
| RS1057520116 |
GRIN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1057520122 |
ALG1
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG1-congenital disorder of glycosylation, Congenital disorder of glycosylation |
| RS1057520127 |
SPAST
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1057520131 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS1057520132 |
TCF12
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypogonadotropic hypogonadism 26 with or without anosmia, Hypogonadotropic hypogonadism 26 with or without anosmia |
| RS1057520134 |
SYNE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS1057520136 |
TBX5
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS1057520142 |
POMT1
|
Health Risk |
Likely pathogenic |
— |
| RS1057520148 |
TTN;TTN-AS1
|
Health Risk |
Pathogenic |
— |
| RS1057520149 |
SCN8A
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Seizure |
| RS1057520152 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Leber congenital amaurosis 8 |
| RS1057520154 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS1057520159 |
IARS1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1057520162 |
RPGRIP1L
|
Health Risk |
Likely pathogenic |
Joubert syndrome, RPGRIP1L-related disorder |
| RS1057520165 |
LAMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Occipital pachygyria and polymicrogyria, Occipital pachygyria and polymicrogyria |
| RS1057520166 |
ARFGEF2
|
Health Risk |
Likely pathogenic |
— |
| RS1057520167 |
KMT2D
|
Health Risk |
Likely pathogenic |
— |
| RS1057520168 |
IRF6
|
Health Risk |
Pathogenic |
— |
| RS1057520174 |
RDX
|
Health Risk |
Likely pathogenic |
— |
| RS1057520175 |
ZEB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1057520177 |
KMT2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1057520178 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS1057520181 |
FBN1
|
Health Risk |
Pathogenic |
— |
| RS1057520186 |
GLRA1
|
Health Risk |
Likely pathogenic |
— |
| RS1057520188 |
PRDM16
|
Health Risk |
Pathogenic |
— |
| RS1057520191 |
CREBBP
|
Health Risk |
Likely pathogenic |
— |
| RS1057520198 |
KDM5C
|
Health Risk |
Likely pathogenic |
— |
| RS1057520200 |
GPR143
|
Health Risk |
Pathogenic |
— |
| RS1057520203 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1057520205 |
CIT
|
Health Risk |
Likely pathogenic |
— |
| RS1057520208 |
PTEN
|
Health Risk |
Pathogenic/Likely pathogenic |
PTEN hamartoma tumor syndrome, PTEN hamartoma tumor syndrome |
| RS1057520209 |
ANOS1
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS1057520210 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS1057520211 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1057520212 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1057520213 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS1057520214 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1057520215 |
ACADM
|
Health Risk |
Conflicting classifications of pathogenicity |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1057520216 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Alpha-actinopathy |
| RS1057520217 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1057520218 |
ADCY5
|
Health Risk |
Likely pathogenic |
— |
| RS1057520224 |
ARID1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1057520233 |
ATP2B2
|
Health Risk |
Conflicting classifications of pathogenicity |
ATP2B2-related Progressive hearing impairment, ATP2B2-related Progressive hearing impairment |
| RS1057520234 |
ATP7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutis laxa, X-linked |
| RS1057520235 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Wilson disease |
| RS1057520237 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1057520246 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1057520249 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1057520261 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS1057520267 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Familial cancer of breast |
| RS1057520275 |
DES
|
Health Risk |
Likely pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS1057520280 |
ERCC8
|
Health Risk |
Likely pathogenic |
— |
| RS1057520291 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Maturity-onset diabetes of the young |